Skip to main content

Table 1 Genomic biomarkers analyzed by molecular cytogenetics

From: Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer

AKT1

CD44

FGFR3

MAP2K1

MYCN

RPS6KB1

AKT2

CDH1

FLT1

MAP2K4

NF1

SHH

AKT3

CDK4

FLT3

MAPK1

NF2

SMAD2

APC

CDKN2A

FMR1

MECOM

NFKBIA

SMAD4

AR

CDKN2C

HRAS

MDM1

NKX2-1

SOX2

ARID1A

CKS1B

IDH1

MDM2

NRAS

STK11

ATM

CTNNB1

IDH2

MDM4

PAK1

SUFU

BCL2

ECT2

IGF1R

MEN1

PBRM1

TNFAIP3

BIRC5

EGFR

INSR

MET

PDGFRA

TOP1

BRAF

ERBB2

JAG1

MGMT

PIK3CA

TOP2A

BRCA1

ERBB3

JAK2

MITF

PTEN

TP53

BRCA2

ERBB4

JUN

MLH1

PTPRD

TSC1

CACNA1E

FAM123B

KDM6A

MSH2

RAB25

TSC2

CCND1

FBXW7

KIT

MYC

RB1

VHL

CCNE1

FGFR1

KRAS

MYCL1

RET

WT1

  1. 90 clinically relevant oncogenes selected from a census of the published literature were analyzed by array CGH in the 18 cases of ovarian carcinoma included in this study.
Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us